Eric Gokcen, MD
Orthopaedic Surgery · Philadelphia, PANPI 1821094764
Payments from drug & device makers
What this record shows
The money is spread across several categories — education (43.2%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Arthrex at 49.0% of the total. Reporting peaked in 2022 at $5,784 and has fallen 74.6% since, to $1,468 in 2025.
Across 98 payments — averaging $85.00 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$4K
- Liberty Surgical Inc.$3K
- Paladin Technology Solutions$735
- Treace Medical Concepts, Inc.$396
- Stryker$185
- Pacira Pharmaceuticals Incorporated$51
- plus $287 from 11 others
Across 1 payment — averaging $38,702 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Orthofix Medical, Inc.$39K
What the payments were for
- Travel & lodging$1,98424%
- Food & beverage$2,74633%
- Education$3,60043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 24 | $4,078 |
| Liberty Surgical Inc. | 23 | $2,598 |
| Paladin Technology Solutions | 10 | $735 |
| Treace Medical Concepts, Inc. | 17 | $396 |
| Stryker(2 entities) | 8 | $185 |
| Pacira Pharmaceuticals Incorporated | 2 | $51 |
| Eclipse Technology Solutions Inc. | 1 | $49 |
| Orthofix Medical, Inc. | 3 | $45 |
| Johnson & Johnson | 2 | $45 |
| Novastep Inc. | 1 | $33 |
| Heraeus Medical, LLC. | 1 | $21 |
| Paragon 28, Inc. | 1 | $18 |
| Globus Medical | 1 | $17 |
| Acumed LLC | 1 | $16 |
| Smith+Nephew | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Kerecis Limited | 1 | $12 |
How this compares
$8,330 in reported general payments places this provider in the 65th percentile of 1,048 orthopaedic surgery providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 14 | $205 |
| Methylprednisolone | 12 | $58 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $19 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Philadelphia
- John FenlinPhiladelphia$5.9M
- Alexander VaccaroPhiladelphia$4.5M
- Joseph AbboudPhiladelphia$3.9M
- Samir MehtaPhiladelphia$3.6M
- Surena NamdariPhiladelphia$1.8M
- Neil ShethPhiladelphia$522K
- Amrit KhalsaPhiladelphia$475K
- Vahid EntezariPhiladelphia$393K
- Charles NelsonPhiladelphia$345K
- David GlaserPhiladelphia$176K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.